Medications

Cost of epilepsy meds continues to soar

Costs for epilepsy medications in the United States are skyrocketing, outpacing inflation and straining federal insurers Medicare and Medicaid, according to new research.

Diseases, Conditions, Syndromes

As hepatitis C proliferates, states lift barriers to treatment

While national efforts to eliminate hepatitis C have faced setbacks because of increased drug use, the impact of COVID-19 and insurance complications, there's a bright spot: Some states are now making it easier for patients ...

page 18 from 40